Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0000950170-24-082416

Principal Accounting Officer sold 1,610 shares at $3.83 ($6,166)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Dunn Edmund Principal Accounting Officer 2024-07-05 Sale −1,610 $3.83 $6,166 13,944 D
Open-market sales · 1,610 sh · avg $3.83 · $6,166
Loading xslF345X05/ownership.xml…